{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:21:29Z","timestamp":1782476489999,"version":"3.54.5"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,29]]},"DOI":"10.7759\/cureus.107939","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:51:55Z","timestamp":1777449115000},"source":"Crossref","is-referenced-by-count":1,"title":["Statin-Associated Severe Rhabdomyolysis With Mixed Neuromuscular Involvement Mimicking Guillain\u2011Barr\u00e9 Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Abhijit","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhayan","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanta","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","volume":"36","author":"Stroes ES","year":"2015","unstructured":"Stroes ES, Thompson PD, Corsini A, et al.. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J. 2015, 36:1012-22. 10.1093\/eurheartj\/ehv043","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1506163","article-title":"Intravenous immune globulin for statin-triggered autoimmune myopathy","volume":"373","author":"Mammen AL","year":"2015","unstructured":"Mammen AL, Tiniakou E. Intravenous immune globulin for statin-triggered autoimmune myopathy. N Engl J Med. 2015, 373:1680-2. 10.1056\/NEJMc1506163","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2010.02984.x","article-title":"Severe statin-induced rhabdomyolysis mimicking Guillain-Barr\u00e9 syndrome in four patients with diabetes mellitus treated with fusidic acid","volume":"27","author":"Collidge TA","year":"2010","unstructured":"Collidge TA, Razvi S, Nolan C, et al.. Severe statin-induced rhabdomyolysis mimicking Guillain-Barr\u00e9 syndrome in four patients with diabetes mellitus treated with fusidic acid. Diabet Med. 2010, 27:696-700. 10.1111\/j.1464-5491.2010.02984.x","journal-title":"Diabet Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.58.5.625","article-title":"Peripheral neuropathy associated with simvastatin","volume":"58","author":"Phan T","year":"1995","unstructured":"Phan T, McLeod JG, Pollard JD, Peiris O, Rohan A, Halpern JP. Peripheral neuropathy associated with simvastatin. J Neurol Neurosurg Psychiatry. 1995, 58:625-8. 10.1136\/jnnp.58.5.625","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.58.9.1333","article-title":"Statins and risk of polyneuropathy: a case-control study","volume":"58","author":"Gaist D","year":"2002","unstructured":"Gaist D, Jeppesen U, Andersen M, Rodr\u00edguez LAG, Hallas J, Sindrup SH. Statins and risk of polyneuropathy: a case-control study. Neurology. 2002, 58:1333-7. 10.1212\/wnl.58.9.1333","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.161","article-title":"SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink","volume":"94","author":"Carr DF","year":"2013","unstructured":"Carr DF, O'Meara H, Jorgensen AL, et al.. SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink. Clin Pharmacol Ther. 2013, 94:695-701. 10.1038\/clpt.2013.161","journal-title":"Clin Pharmacol Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158364","article-title":"Statins neuromuscular adverse effects","volume":"23","author":"Attardo S","year":"2022","unstructured":"Attardo S, Musumeci O, Velardo D, Toscano A. Statins neuromuscular adverse effects. Int J Mol Sci. 2022, 23:8364. 10.3390\/ijms23158364","journal-title":"Int J Mol Sci"},{"key":"ref8","article-title":"Treatment with statins and peripheral neuropathy: results of 36-months a prospective clinical and neurophysiological follow-up","volume":"32","author":"Otruba P","year":"2011","unstructured":"Otruba P, Kanovsky P, Hlustik P. Treatment with statins and peripheral neuropathy: results of 36-months a prospective clinical and neurophysiological follow-up. Neuro Endocrinol Lett. 2011, 32:688-90.","journal-title":"Neuro Endocrinol Lett"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/484808-statin-associated-severe-rhabdomyolysis-with-mixed-neuromuscular-involvement-mimicking-guillainbarr-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:51:56Z","timestamp":1777449116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/484808-statin-associated-severe-rhabdomyolysis-with-mixed-neuromuscular-involvement-mimicking-guillainbarr-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.107939","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,29]]}}}